Local Institution - 0182

Mitaka-shi, Tokyo 181-8611

0 studies enrolling now · 1 studies all time

What they study most

Hepatocellular Carcinoma, Liver Cancer

Studies at this site

• A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation — Running, not enrolling